• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical practice guidelines for acute-on-chronic liver failure: are we ready for reaching global consensus?

作者信息

Engelmann Cornelius, Berg Thomas

机构信息

Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Berlin, Germany.

Division of Hepatology, Department of Medicine II, Leipzig University Medical Center, Leipzig, Germany.

出版信息

Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):239-243. doi: 10.21037/hbsn-23-6. Epub 2023 Mar 27.

DOI:10.21037/hbsn-23-6
PMID:37124683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10129877/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5523/10129877/fafb4b036282/hbsn-12-02-239-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5523/10129877/fafb4b036282/hbsn-12-02-239-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5523/10129877/fafb4b036282/hbsn-12-02-239-f1.jpg

相似文献

1
Clinical practice guidelines for acute-on-chronic liver failure: are we ready for reaching global consensus?《急性慢性肝衰竭临床实践指南：我们准备好达成全球共识了吗？》
Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):239-243. doi: 10.21037/hbsn-23-6. Epub 2023 Mar 27.
2
Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study).粒细胞集落刺激因子（G-CSF）治疗慢加急性肝衰竭：一项多中心随机试验（GRAFT 研究）。
J Hepatol. 2021 Dec;75(6):1346-1354. doi: 10.1016/j.jhep.2021.07.033. Epub 2021 Aug 5.
3
Granulocyte Colony-Stimulating Factor Accelerates the Recovery of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure by Promoting M2-Like Transition of Monocytes.粒细胞集落刺激因子通过促进单核细胞向 M2 样表型转化加速乙型肝炎病毒相关慢加急性肝衰竭的恢复。
Front Immunol. 2022 May 16;13:885829. doi: 10.3389/fimmu.2022.885829. eCollection 2022.
4
Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage.粒细胞集落刺激因子治疗慢加急性肝衰竭患者的疗效：提高生存率，减轻肝损伤。
Hepatol Int. 2017 Nov;11(6):540-546. doi: 10.1007/s12072-017-9814-1. Epub 2017 Aug 24.
5
Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF.粒细胞集落刺激因子（G-CSF）与Toll样受体4（TLR4）抑制剂联合使用可减轻急性肝衰竭（ACLF）小鼠模型中的炎症并促进再生。
J Hepatol. 2022 Nov;77(5):1325-1338. doi: 10.1016/j.jhep.2022.07.006. Epub 2022 Jul 16.
6
Effect of Granulocyte Colony-stimulating Factor and Erythropoietin on Patients with Acute-on-chronic Liver Failure.粒细胞集落刺激因子和促红细胞生成素对慢性重型肝炎患者的影响
Euroasian J Hepatogastroenterol. 2020 Jul-Dec;10(2):64-67. doi: 10.5005/jp-journals-10018-1330.
7
Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis.粒细胞集落刺激因子用于慢性肝衰竭急性发作：系统评价与荟萃分析
Ann Hepatol. 2015 Sep-Oct;14(5):631-41.
8
Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure.粒细胞集落刺激因子治疗可改善乙型肝炎病毒相关慢加急性肝衰竭患者的生存。
World J Gastroenterol. 2013 Feb 21;19(7):1104-10. doi: 10.3748/wjg.v19.i7.1104.
9
Altered frequencies of dendritic cells and IFN-gamma-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure.慢性加急性肝衰竭患者经粒细胞集落刺激因子（G-CSF）治疗后树突状细胞和 IFN-γ 分泌 T 细胞的频率改变。
Liver Int. 2014 Apr;34(4):505-13. doi: 10.1111/liv.12415.
10
The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure.粒细胞集落刺激因子治疗慢加急性肝衰竭的现状。
Semin Liver Dis. 2021 Aug;41(3):298-307. doi: 10.1055/s-0041-1723034. Epub 2021 May 15.

引用本文的文献

1
EASL-CLIF, NACSELD and APASL definitions for identification of acute-on-chronic liver failure and its outcome in a non-transplant setting.欧洲肝脏研究学会-慢性肝衰竭（EASL-CLIF）、北美终末期肝病研究联盟（NACSELD）和亚太肝脏研究学会（APASL）关于在非移植情况下识别慢加急性肝衰竭及其预后的定义。
Indian J Gastroenterol. 2025 May 21. doi: 10.1007/s12664-025-01769-5.
2
Palliative care for end-stage liver disease and acute on chronic liver failure: A systematic review.终末期肝病和慢性肝衰竭急性发作的姑息治疗：一项系统评价。
World J Methodol. 2024 Dec 20;14(4):95904. doi: 10.5662/wjm.v14.i4.95904.
3
[Liver transplantation in acute and acute-on-chronic liver failure].

本文引用的文献

1
Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLF.粒细胞集落刺激因子（G-CSF）与Toll样受体4（TLR4）抑制剂联合使用可减轻急性肝衰竭（ACLF）小鼠模型中的炎症并促进再生。
J Hepatol. 2022 Nov;77(5):1325-1338. doi: 10.1016/j.jhep.2022.07.006. Epub 2022 Jul 16.
2
IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.白细胞介素-1 受体拮抗剂联合己酮可可碱和锌治疗严重酒精相关性肝炎。
Hepatology. 2022 Oct;76(4):1058-1068. doi: 10.1002/hep.32478. Epub 2022 Jun 2.
3
Acute-on-Chronic Liver Failure Clinical Guidelines.
[急性和慢加急性肝衰竭中的肝移植]
Med Klin Intensivmed Notfmed. 2024 Sep;119(6):484-492. doi: 10.1007/s00063-024-01158-4. Epub 2024 Jul 23.
4
Challenges in Diagnosis and Therapeutic Approach of Acute on Chronic Liver Failure-A Review of Current Evidence.慢性肝功能衰竭急性发作的诊断与治疗方法面临的挑战——当前证据综述
Biomedicines. 2023 Jun 26;11(7):1840. doi: 10.3390/biomedicines11071840.
急性加重慢性肝衰竭临床指南。
Am J Gastroenterol. 2022 Feb 1;117(2):225-252. doi: 10.14309/ajg.0000000000001595.
4
The role of RIPK1 mediated cell death in acute on chronic liver failure.RIPK1 介导的细胞死亡在急性加重慢性肝衰竭中的作用。
Cell Death Dis. 2021 Dec 17;13(1):5. doi: 10.1038/s41419-021-04442-9.
5
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.拯救脓毒症运动：2021年脓毒症和脓毒性休克国际管理指南
Crit Care Med. 2021 Nov 1;49(11):e1063-e1143. doi: 10.1097/CCM.0000000000005337.
6
The Prediction of In-Hospital Mortality in Decompensated Cirrhosis with Acute-on-Chronic Liver Failure.失代偿期肝硬化合并慢加急性肝衰竭患者院内死亡率的预测
Liver Transpl. 2022 Apr;28(4):560-570. doi: 10.1002/lt.26311. Epub 2021 Nov 9.
7
Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study).粒细胞集落刺激因子（G-CSF）治疗慢加急性肝衰竭：一项多中心随机试验（GRAFT 研究）。
J Hepatol. 2021 Dec;75(6):1346-1354. doi: 10.1016/j.jhep.2021.07.033. Epub 2021 Aug 5.
8
Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction.失代偿期肝硬化的病理生理学：门静脉高压、循环功能障碍、炎症、代谢和线粒体功能障碍。
J Hepatol. 2021 Jul;75 Suppl 1(Suppl 1):S49-S66. doi: 10.1016/j.jhep.2021.01.002.
9
Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure.Toll 样受体 4 是防治肝衰竭的治疗靶点。
J Hepatol. 2020 Jul;73(1):102-112. doi: 10.1016/j.jhep.2020.01.011. Epub 2020 Jan 24.
10
Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region.并发症是乙型肝炎病毒相关慢加急性肝衰竭患者死亡的主要危险因素：亚太地区的一项多国家研究。
Hepatol Int. 2019 Nov;13(6):695-705. doi: 10.1007/s12072-019-09992-x. Epub 2019 Oct 24.